|
 |
|
|
|
|
62-Year-Old Man Becomes First Patient In China Implanted With Rechargeable Neurostimulator For Chronic Pain (Medical News Today)
Thu Nov 19 18:37:19 PST 2009
St. Jude Medical, Inc. (NYSE:STJ) announced that a 62-year-old man from Shenzhen, Guangdong province has become the first patient in China to be implanted with the Eon™ neurostimulator, a rechargeable device used to help manage chronic pain. Despite prior back surgeries, the patient suffered from...
Read full article »
|
|
Nutra Pharma Introduces Chronic Pain Reliever, Nyloxin OTC, for International Distribution (Business Wire via Yahoo! Finance)
Thu Nov 19 06:03:00 PST 2009
PLANTATION, Fla.----Nutra Pharma Corp. , a biotechnology company that is developing treatments for Adrenomyeloneuropathy , HIV and Multiple Sclerosis , has announced today the introduction of Nyloxin OTC for the treatment of chronic pain.
Read full article »
|
|
Nutra Pharma Introduces Chronic Pain Reliever, Nyloxin OTC, for International Distribution (PRWeb)
Thu Nov 19 13:52:33 PST 2009
Nutra Pharma has introduced Nyloxin OTC, an over-the-counter pain reliever, that will be marketed and sold through international distribution channels alongside the Company's prescription pain reliever, Nyloxin Rx. (PRWeb Nov 20, 2009) Read the full story at...
Read full article »
|
|
Nutra Pharma Introduces Chronic Pain Reliever, Nyloxin OTC, for International Distribution (PRWeb via Yahoo! News)
Thu Nov 19 05:30:00 PST 2009
Nutra Pharma has introduced Nyloxin OTC, an over-the-counter pain reliever, that will be marketed and sold through international distribution channels alongside the Company's prescription pain reliever, Nyloxin Rx.
Read full article »
|
|
Sucampo Receives Marketing Authorization For Amitiza(R) In Switzerland For Treatment Of Chronic Idiopathic Constipation (Medical News Today)
Sat Nov 21 00:37:19 PST 2009
Sucampo Pharma Europe Ltd., a subsidiary of Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP), announced that Swissmedic, the Swiss Agency for Therapeutic Products, has granted a marketing authorization for Amitiza® (lubiprostone) 24 microgram (mcg) gel capsules for the long-term treatment of patients...
Read full article »
|
|
Common Pain Relief Medication May Encourage Cancer Growth (Medical News Today)
Thu Nov 19 05:38:59 PST 2009
Although morphine has been the gold-standard treatment for postoperative and chronic cancer pain for two centuries, a growing body of evidence is showing that opiate-based painkillers can stimulate the growth and spread of cancer cells.
Read full article »
|
|
Depression Patients More Apt to Receive Opioids for Chronic Pain (PhysOrg)
Mon Nov 16 15:53:00 PST 2009
Chronic pain patients with a history of depression are three times more likely to receive long-term prescriptions for opioid medications like Vicodin compared to pain patients who do not suffer from depression, according to new research.
Read full article »
|
|
Common pain relief medication may encourage cancer growth (Science Daily)
Wed Nov 18 20:25:18 PST 2009
Although morphine has been the gold-standard treatment for postoperative and chronic cancer pain for two centuries, a growing body of evidence is showing that opiate-based painkillers can stimulate the growth and spread of cancer cells. Two new studies advance that argument and demonstrate how...
Read full article »
|
|
Seniors May Find Relief from Pain, Distress of I llness in Free Palliative Care Brochure (Senior Journal)
Fri Nov 20 09:26:26 PST 2009
Nov. 20, 2009 – The pain and distress that too many senior citizens battle when afflicted with serious illness can be managed with palliative care.
Read full article »
|
|
Common pain relief medication may encourage cancer growth (EurekAlert!)
Wed Nov 18 09:28:38 PST 2009
( University of Chicago Medical Center ) Although morphine has been the gold-standard treatment for postoperative and chronic cancer pain for two centuries, a growing body of evidence is showing that opiate-based painkillers can stimulate the growth and spread of cancer cells. Two new studies...
Read full article »
|
